Innovating Works

Synovo

Desconocido
EvaMobs: Evolvable and rapidly adaptable monobodies: a broad-spectrum antiviral platform SYNOVO GMBH participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 With progress in globalization, expansion of human populations into natural habitats, and aggravation of climate change comes an increased r...
2023-11-23 - 2028-12-31 | Financiado
Algae4IBD: ALGAE4IBD FROM NATURE TO BEDSIDE ALGAE BASED BIO COMPOUND FOR PREVENTION AND TREATMENT OF INFLAMMA... SYNOVO GMBH participó en un H2020: H2020-FNR-2020 Algae4IBD's mission is to develop commercial products for Inflammatory Bowel Disease (IBD) prevention and treatment using aquatic natural bi...
2021-05-03 - 2025-05-31 | Financiado
NOVIRUSES2BRAIN: One size fits all unique drug to eradicate multiple viral species simultaneously from the centra... SYNOVO GMBH participó en un H2020: H2020-FETOPEN-2018-2020 Viruses that infect the brain and other parts of the central nervous system are a worldwide threat of terrible dimensions. Viruses such as Z...
2018-12-17 - 2025-08-31 | Financiado
FOLSMART: Folate Target Nanodevices To Activated Macrophages For Rheumatoid Arthritis SYNOVO GMBH participó en un H2020: H2020-NMP-2014-2015 FOLSMART will bring to phase I clinical trials novel folate-based nanodevices (FBN) for the treatment of rheumatoid arthritis (RA). These na...
2015-11-25 - 2020-12-31 | Financiado
KINACEPT: Novel anti inflammatory compounds for autoimmune diseases SYNOVO GMBH tramitó un FP7: The consortium has a lead series of p38 inhibitors with unusual anti-inflammatory properties. The drug leads were originally elaborated...
Financiado
InFact: Functional materials for fast diagnosis of wound infection SYNOVO GMBH participó en un FP7: "Early detection of an incipient wound infection is a challenge for the attending physician , since its early diagnosis allows the timely i...
Financiado
NOVO: Novel approaches for prevention and degeneration of pathogenic bacteria biofilms formed on medical d... SYNOVO GMBH participó en un FP7: Biofilms are bacterial communities encased in a self-produced hydrated polymeric matrix. An important characteristic of microbial biofilms i...
Financiado
PEP2BRAIN: Selected peptides as drug candidates directed to pain and neurodegeneration SYNOVO GMBH participó en un FP7: "BLV200703/4 is a small molecule discovered jointly by groups from the University of Lisbon (Portugal) and Girona (Spain) that proved its ef...
Financiado
TIMCC: Tumor Infiltrating Myeloid Cell Compartment SYNOVO GMBH participó en un FP7: The ITN TIMCC brings together eight expert teams from different disciplines within Immunology, Genetics and Oncology, to provide substantive...
Financiado
VISION: Prolonged inhibition of semaphorine3a pathway via a bio degradable implant towards a better therapy... SYNOVO GMBH participó en un FP7: The visual pathway is a component of the central nervous system (CNS) and therefore is not regenerative. Acute optic nerve injury, ischemic...
Financiado
NANOFOL: Folate based nanobiodevices for integrated diagnosis therapy targeting chronic inflammatory diseases SYNOVO GMBH participó en un FP7: NANOFOL proposes to develop a new diagnostic/therapy approach using folate based nanobiodevices (FBN) able to provide a new type of cost eff...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.